Header cover image
  • Investing Ideas
  • German Pharmaceuticals & Biotech Undervalued over 20% based on DCF

German Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Dermapharm Holding

Market Cap: €2.3b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

DMP

€45.55

7D

-3.0%

1Y

30.1%